Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial by Menter, Alan, MD, Tyring, Stephen K., MD, PhD, MBA, Gordon, Kenneth, MD, Kimball, Alexa B., MD, MPH, Leonardi, Craig L., MD, Langley, Richard G., MD, Strober, Bruce E., MD, PhD, Kaul, Martin, MD, Gu, Yihua, MS, Okun, Martin, MD, PhD, Papp, Kim, MD

Get full text

Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients... by Gordon, Kenneth, MD, Papp, Kim, MD, PhD, Poulin, Yves, MD, Gu, Yihua, MS, Rozzo, Stephen, PhD, Sasso, Eric H., MD

Get full text

Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis by Menter, Alan, MD, Gordon, Kenneth B., MD, Leonardi, Craig L., MD, Gu, Yihua, MS, Goldblum, Orin M., MD

Get full text

Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study by Strober, Bruce E., MD, PhD, Poulin, Yves, MD, Kerdel, Francisco A., MD, Langley, Richard G., MD, Gu, Yihua, MS, Gupta, Shiraz R., PharmD, MPH, Okun, Martin M., MD, PhD, Papp, Kim A., MD, PhD

Get full text